Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

Completed · Phase 1 · Has a placebo group

Conditions studied: Acute Blood Loss Anemia, Osteoarthritis, Hip

In brief

This study aims to assess postoperative blood loss and transfusion rates in total hip replacement after one-time administration of topical tranexamic acid.

Key facts

Study ID

NCT01683955

Run by

Henry Ford Health System

People needed

139

Starts

2013-01-01

Expected to finish

2013-11-03

Last updated by the study team

2023-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All adult patients over age eighteen
• Primary unilateral total hip arthroplasty at Henry Ford Hospital (Detroit, Michigan, United States) and Henry Ford West Bloomfield Hospital (West Bloomfield, Michigan, United States)

You may not qualify if…

• patient history of venous thromboembolic disease or coagulopathy
• use of anticoagulant medications within 7 days of surgery
• history of arterial embolic disease
• history of Class III or IV heart failure
• renal failure
• intraoperative cardiovascular, pulmonary, orthopaedic, or anesthetic complication (MI, intraoperative fracture, vasopressor support, emergent intubation).

Where it is running

• Henry Ford Hospital — Detroit, Michigan, United States
• HFH Main campus — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.